• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAffimed NV
    Picture of Affimed NV logo

    AFMDQ — Affimed NV News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      -$12.57m
    • Revenue
      €8.28m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AFMDQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AFMDQ Dividends
    All News

    NASDAQ RESUMED

    Picture of Affimed NV logoAffimed NV
    27/08/2018 21:40
    NASDAQ RESUMED  AFMD.O
    

    Recent news on Affimed NV

    See all news
    • Brief: Affimed Announces Receipt Of Nasdaq Delisting Notice

      14/05/2025 12:50
    • Brief: Affimed Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

      21/04/2025 12:53
    • Brief: Affimed Reports Positive Clinical Update On Afm24/Atezolizumab Combination Therapy

      17/12/2024 11:37
    • Brief: Affimed NV Files For Common Stock Offering Of Up To $20 Million - SEC Filing

      08/11/2024 22:25
    • Brief: Affimed NV Files For Mixed Shelf Offering Of Up To $20 Million

      04/11/2024 18:10

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.